Profile
Joël Richard is currently a member of the Scientific & Medical Council at GlioCure SAS.
He previously worked as the Managing Director at OctreoPharm Sciences GmbH, Development Director at Ipsen Dreux, and Senior Vice President-Pharma Development at Ipsen SA. He is also currently serving as the Chief Scientific Officer at MedinCell SA, a position he has held since 2022 and will continue until 2023.
Joël Richard active positions
| Companies | Position | Start |
|---|---|---|
GlioCure SAS
 GlioCure SAS BiotechnologyHealth Technology GlioCure SAS is a French biopharmaceutical company that focuses on discovering and developing new drugs to treat glioma and pediatric brain tumors. The private company is based in Angers, France. | Corporate Officer/Principal | - |
Former positions of Joël Richard
| Companies | Position | End |
|---|---|---|
| MEDINCELL S.A. | Chief Tech/Sci/R&D Officer | 31/01/2023 |
| IPSEN | Corporate Officer/Principal | - |
| Ipsen Dreux | Corporate Officer/Principal | - |
OctreoPharm Sciences GmbH
 OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology OctreoPharm Sciences GmbH develops and manufactures pharmaceutical products. It operates as a clinical development biopharmaceutical company which focuses on radiopharmaceuticals for the diagnosis and therapeutic control of tumors. The company was founded by Hakim Larbi Bouterfa and Udo Blaseg in 2010 and is headquartered in Berlin, Germany. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IPSEN | Health Technology |
| MEDINCELL S.A. | Health Technology |
| Private companies | 3 |
|---|---|
OctreoPharm Sciences GmbH
OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology OctreoPharm Sciences GmbH develops and manufactures pharmaceutical products. It operates as a clinical development biopharmaceutical company which focuses on radiopharmaceuticals for the diagnosis and therapeutic control of tumors. The company was founded by Hakim Larbi Bouterfa and Udo Blaseg in 2010 and is headquartered in Berlin, Germany. | Health Technology |
GlioCure SAS
GlioCure SAS BiotechnologyHealth Technology GlioCure SAS is a French biopharmaceutical company that focuses on discovering and developing new drugs to treat glioma and pediatric brain tumors. The private company is based in Angers, France. | Health Technology |
| Ipsen Dreux |
- Stock Market
- Insiders
- Joël Richard
